{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:59:03Z","timestamp":1790276343583,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"DOI":"10.1007\/s40121-026-01448-8","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:01:07Z","timestamp":1790269267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nucleic Acid-Based Antimicrobial Strategies Against Drug-Resistant Staphylococcus aureus: A Review of Mechanisms of Action and Delivery Approaches"],"prefix":"10.1007","author":[{"given":"Reza","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6869-2301","authenticated-orcid":false,"given":"Hamid","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"1448_CR1","doi-asserted-by":"crossref","unstructured":"Abushaheen MA, Muzaheed, Fatani AJ, Alosaimi M, Mansy W, George M, et al. Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon. 2020;66(6):100971.","DOI":"10.1016\/j.disamonth.2020.100971"},{"key":"1448_CR2","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18604","volume":"12","author":"ENS Engku Abd Rahman","year":"2024","unstructured":"Engku Abd Rahman ENS, Irekeola AA, Yamin D, Elmi AH, Chan YY. Charting the global footprint of borderline oxacillin-resistant Staphylococcus aureus (BORSA): the first systematic review and meta-analysis. PeerJ. 2024;12:e18604.","journal-title":"PeerJ"},{"issue":"1","key":"1448_CR3","volume":"17","author":"S Christina","year":"2025","unstructured":"Christina S, Praveena R, Saikumar C. Emerging resistance mechanisms in Gram-positive bacteria isolated from septicemia cases in ICUs: a focus on genotypic insights. Cureus. 2025;17(1):e76979.","journal-title":"Cureus"},{"issue":"1","key":"1448_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","volume":"12","author":"GYC Cheung","year":"2021","unstructured":"Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547\u201369.","journal-title":"Virulence"},{"key":"1448_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158088","author":"B Mlynarczyk-Bonikowska","year":"2022","unstructured":"Mlynarczyk-Bonikowska B, Kowalewski C, Krolak-Ulinska A, Marusza W. Molecular mechanisms of drug resistance in Staphylococcus aureus. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23158088.","journal-title":"Int J Mol Sci"},{"key":"1448_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14050470","author":"R Touaitia","year":"2025","unstructured":"Touaitia R, Mairi A, Ibrahim NA, Basher NS, Idres T, Touati A. Staphylococcus aureus: a review of the pathogenesis and virulence mechanisms. Antibiotics (Basel). 2025. https:\/\/doi.org\/10.3390\/antibiotics14050470.","journal-title":"Antibiotics (Basel)"},{"key":"1448_CR7","doi-asserted-by":"publisher","first-page":"7641","DOI":"10.2147\/IDR.S428103","volume":"16","author":"AA Abebe","year":"2023","unstructured":"Abebe AA, Birhanu AG. Methicillin resistant staphylococcus aureus: molecular mechanisms underlying drug resistance development and novel strategies to combat. Infect Drug Resist. 2023;16:7641\u201362.","journal-title":"Infect Drug Resist"},{"key":"1448_CR8","doi-asserted-by":"crossref","unstructured":"Bhattacharya S, Bir R, Majumdar T. Evaluation of multidrug resistant Staphylococcus aureus and their association with biofilm production in a Tertiary Care Hospital, Tripura, Northeast India. J Clin Diagn Res. 2015;9(9):Dc01\u20134.","DOI":"10.7860\/JCDR\/2015\/13965.6417"},{"issue":"6","key":"1448_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1517\/17460441.2015.1048219","volume":"10","author":"R Penchovsky","year":"2015","unstructured":"Penchovsky R, Traykovska M. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do? Expert Opin Drug Discov. 2015;10(6):631\u201350.","journal-title":"Expert Opin Drug Discov"},{"key":"1448_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2147\/IDR.S510024","volume":"18","author":"K Shao","year":"2025","unstructured":"Shao K, Yang Y, Gong X, Chen K, Liao Z, Ojha SC. Staphylococcal drug resistance: mechanisms, therapies, and nanoparticle interventions. Infect Drug Resist. 2025;18:1007\u201333.","journal-title":"Infect Drug Resist"},{"key":"1448_CR11","doi-asserted-by":"crossref","unstructured":"Michalik M, Podbielska-Kubera A, Dmowska-Koroblewska A. Antibiotic Resistance of Staphylococcus aureus strains-searching for new antimicrobial agents-review. Pharmaceuticals (Basel). 2025;18(1):81.","DOI":"10.3390\/ph18010081"},{"issue":"1","key":"1448_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40121-024-01069-z","volume":"14","author":"M Golban","year":"2025","unstructured":"Golban M, Charostad J, Kazemian H, Heidari H. Phage-derived endolysins against resistant Staphylococcus spp.: a review of features, antibacterial activities, and recent applications. Infect Dis Ther. 2025;14(1):13\u201357.","journal-title":"Infect Dis Ther"},{"key":"1448_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13030221","author":"R Penchovsky","year":"2024","unstructured":"Penchovsky R, Georgieva AV, Dyakova V, Traykovska M, Pavlova N. Antisense and functional nucleic acids in rational drug development. Antibiotics (Basel). 2024. https:\/\/doi.org\/10.3390\/antibiotics13030221.","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"1448_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107083","volume":"63","author":"M El-Fateh","year":"2024","unstructured":"El-Fateh M, Chatterjee A, Zhao X. A systematic review of peptide nucleic acids (PNAs) with antibacterial activities: efficacy, potential and challenges. Int J Antimicrob Agents. 2024;63(3):107083.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"1448_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102122","volume":"35","author":"L Moreira","year":"2024","unstructured":"Moreira L, Guimar\u00e3es NM, Santos RS, Loureiro JA, Pereira MC, Azevedo NF. Promising strategies employing nucleic acids as antimicrobial drugs. Mol Ther Nucleic Acids. 2024;35(1):102122.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"1448_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/jam.13321","volume":"122","author":"F Da","year":"2017","unstructured":"Da F, Yao L, Su Z, Hou Z, Li Z, Xue X, et al. Antisense locked nucleic acids targeting agrA inhibit quorum sensing and pathogenesis of community-associated methicillin-resistant Staphylococcus aureus. J Appl Microbiol. 2017;122(1):257\u201367.","journal-title":"J Appl Microbiol"},{"issue":"6","key":"1448_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12275-019-8635-4","volume":"57","author":"HT Lee","year":"2019","unstructured":"Lee HT, Kim SK, Yoon JW. Antisense peptide nucleic acids as a potential anti-infective agent. J Microbiol. 2019;57(6):423\u201330.","journal-title":"J Microbiol"},{"issue":"6","key":"1448_CR18","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/0006-2952(94)90171-6","volume":"48","author":"VV Demidov","year":"1994","unstructured":"Demidov VV, Potaman VN, Frank-Kamenetskii MD, Egholm M, Buchard O, S\u00f6nnichsen SH, et al. Stability of peptide nucleic acids in human serum and cellular extracts. Biochem Pharmacol. 1994;48(6):1310\u20133.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1448_CR19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.nano.2017.12.026","volume":"14","author":"XY Xue","year":"2018","unstructured":"Xue XY, Mao XG, Zhou Y, Chen Z, Hu Y, Hou Z, et al. Advances in the delivery of antisense oligonucleotides for combating bacterial infectious diseases. Nanomedicine. 2018;14(3):745\u201358.","journal-title":"Nanomedicine"},{"issue":"3","key":"1448_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00253-017-8671-0","volume":"102","author":"JP Hegarty","year":"2018","unstructured":"Hegarty JP, Stewart DB Sr. Advances in therapeutic bacterial antisense biotechnology. Appl Microbiol Biotechnol. 2018;102(3):1055\u201365.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"40","key":"1448_CR21","doi-asserted-by":"publisher","first-page":"47987","DOI":"10.1021\/acsami.1c15585","volume":"13","author":"Q Long","year":"2021","unstructured":"Long Q, Jia B, Shi Y, Wang Q, Yu H, Li Z. DNA nanodevice as a co-delivery vehicle of antisense oligonucleotide and silver ions for selective inhibition of bacteria growth. ACS Appl Mater Interfaces. 2021;13(40):47987\u201395.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"1448_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ja.2014.132","volume":"68","author":"J Meng","year":"2015","unstructured":"Meng J, He G, Wang H, Jia M, Ma X, Da F, et al. Reversion of antibiotic resistance by inhibiting mecA in clinical methicillin-resistant Staphylococci by antisense phosphorothioate oligonucleotide. J Antibiot (Tokyo). 2015;68(3):158\u201364.","journal-title":"J Antibiot (Tokyo)"},{"issue":"1","key":"1448_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1517\/17460441.2013.740455","volume":"8","author":"R Penchovsky","year":"2013","unstructured":"Penchovsky R, Stoilova CC. Riboswitch-based antibacterial drug discovery using high-throughput screening methods. Expert Opin Drug Discov. 2013;8(1):65\u201382.","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"1448_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2020.194501","volume":"1863","author":"AV B\u00e9dard","year":"2020","unstructured":"B\u00e9dard AV, Hien EDM, Lafontaine DA. Riboswitch regulation mechanisms: RNA, metabolites and regulatory proteins. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2020;1863(3):194501.","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"1448_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10010045","author":"V Panchal","year":"2021","unstructured":"Panchal V, Brenk R. Riboswitches as drug targets for antibiotics. Antibiotics (Basel). 2021. https:\/\/doi.org\/10.3390\/antibiotics10010045.","journal-title":"Antibiotics (Basel)"},{"key":"1448_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11111662","author":"M Traykovska","year":"2022","unstructured":"Traykovska M, Penchovsky R. Targeting SAM-I riboswitch using antisense oligonucleotide technology for inhibiting the growth of Staphylococcus aureus and Listeria monocytogenes. Antibiotics (Basel). 2022. https:\/\/doi.org\/10.3390\/antibiotics11111662.","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"1448_CR27","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1021\/acssynbio.2c00013","volume":"11","author":"M Traykovska","year":"2022","unstructured":"Traykovska M, Penchovsky R. Engineering antisense oligonucleotides as antibacterial agents that target FMN riboswitches and inhibit the growth of Staphylococcus aureus, Listeria monocytogenes, and Escherichia coli. ACS Synth Biol. 2022;11(5):1845\u201355.","journal-title":"ACS Synth Biol"},{"issue":"11","key":"1448_CR28","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1021\/acssynbio.1c00443","volume":"10","author":"M Traykovska","year":"2021","unstructured":"Traykovska M, Popova KB, Penchovsky R. Targeting glmS ribozyme with chimeric antisense oligonucleotides for antibacterial drug development. ACS Synth Biol. 2021;10(11):3167\u201376.","journal-title":"ACS Synth Biol"},{"issue":"1","key":"1448_CR29","doi-asserted-by":"publisher","DOI":"10.4142\/jvs.23265","volume":"25","author":"SK Kim","year":"2024","unstructured":"Kim SK, Lee JB, Lee HT, Yoon JW. Combined antimicrobial effect of two peptide nucleic acids against Staphylococcus aureus and S. pseudintermedius veterinary isolates. J Vet Sci. 2024;25(1):e12.","journal-title":"J Vet Sci"},{"key":"1448_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13020122","author":"KB Popova","year":"2024","unstructured":"Popova KB, Penchovsky R. General and specific cytotoxicity of chimeric antisense oligonucleotides in bacterial cells and human cell lines. Antibiotics (Basel). 2024. https:\/\/doi.org\/10.3390\/antibiotics13020122.","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"1448_CR31","doi-asserted-by":"publisher","first-page":"6453","DOI":"10.1021\/acsami.1c23808","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lai L, Liu Y, Chen B, Yao J, Zheng P, et al. Biomineralized cascade enzyme-encapsulated ZIF-8 nanoparticles combined with antisense oligonucleotides for drug-resistant bacteria treatment. ACS Appl Mater Interfaces. 2022;14(5):6453\u201364.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"1448_CR32","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1021\/acs.nanolett.8b02166","volume":"18","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Ma W, Zhu Y, Shi S, Li Q, Mao C, et al. Inhibiting methicillin-resistant Staphylococcus aureus by tetrahedral DNA nanostructure-enabled antisense peptide nucleic acid delivery. Nano Lett. 2018;18(9):5652\u20139.","journal-title":"Nano Lett"},{"key":"1448_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2014.09.015","volume":"30","author":"S Liang","year":"2015","unstructured":"Liang S, He Y, Xia Y, Wang H, Wang L, Gao R, et al. Inhibiting the growth of methicillin-resistant Staphylococcus aureus in vitro with antisense peptide nucleic acid conjugates targeting the ftsZ gene. Int J Infect Dis. 2015;30:1\u20136.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"1448_CR34","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1128\/AAC.03781-14","volume":"59","author":"J Meng","year":"2015","unstructured":"Meng J, Da F, Ma X, Wang N, Wang Y, Zhang H, et al. Antisense growth inhibition of methicillin-resistant Staphylococcus aureus by locked nucleic acid conjugated with cell-penetrating peptide as a novel FtsZ inhibitor. Antimicrob Agents Chemother. 2015;59(2):914\u201322.","journal-title":"Antimicrob Agents Chemother"},{"issue":"19","key":"1448_CR35","doi-asserted-by":"publisher","first-page":"20966","DOI":"10.1021\/acsomega.4c00114","volume":"9","author":"Y Li","year":"2024","unstructured":"Li Y, Hu Y, Kamal Z, Chen Y, Xue X, Yao S, et al. Optimization of dendritic polypeptide delivery system for antisense antibacterial agents targeting ftsZ. ACS Omega. 2024;9(19):20966\u201375.","journal-title":"ACS Omega"},{"issue":"22","key":"1448_CR36","doi-asserted-by":"publisher","first-page":"28041","DOI":"10.1021\/acsami.4c01453","volume":"16","author":"A Li","year":"2024","unstructured":"Li A, Zhang Y, Wan L, Peng R, Zhang X, Guo Q, et al. Coordination-driven self-assembly of metal ion-antisense oligonucleotide nanohybrids for chronic bacterial infection therapy. ACS Appl Mater Interfaces. 2024;16(22):28041\u201355.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1448_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2022.213121","volume":"141","author":"S Wu","year":"2022","unstructured":"Wu S, Gan T, Xie L, Deng S, Liu Y, Zhang H, et al. Antibacterial performance of graphene oxide\/alginate-based antisense hydrogel for potential therapeutic application in Staphylococcus aureus infection. Biomater Adv. 2022;141:213121.","journal-title":"Biomater Adv"},{"issue":"28","key":"1448_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300477","volume":"35","author":"M Liu","year":"2023","unstructured":"Liu M, Chu B, Sun R, Ding J, Ye H, Yang Y, et al. Antisense oligonucleotides selectively enter human-derived antibiotic-resistant bacteria through bacterial-specific ATP-binding cassette sugar transporter. Adv Mater. 2023;35(28):e2300477.","journal-title":"Adv Mater"},{"issue":"4","key":"1448_CR39","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ymthe.2004.07.006","volume":"10","author":"N Nekhotiaeva","year":"2004","unstructured":"Nekhotiaeva N, Awasthi SK, Nielsen PE, Good L. Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol Ther. 2004;10(4):652\u20139.","journal-title":"Mol Ther"},{"issue":"1","key":"1448_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029886","volume":"7","author":"H Bai","year":"2012","unstructured":"Bai H, Sang G, You Y, Xue X, Zhou Y, Hou Z, et al. Targeting RNA polymerase primary \u03c370 as a therapeutic strategy against methicillin-resistant Staphylococcus aureus by antisense peptide nucleic acid. PLoS ONE. 2012;7(1):e29886.","journal-title":"PLoS ONE"},{"key":"1448_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1134\/S106816201906027X","volume":"45","author":"N Mironova","year":"2019","unstructured":"Mironova N, Kupryushkin M, Khlusevitch Y, Matveev A, Tikunova N, Pyshnyi D, et al. Algorithm for searching and testing the activity of antisense oligonucleotides exemplified by the mRNA of the rpoD gene encoding Staphylococcus aureus RNA polymerase sigma factor. Russ J Bioorg Chem. 2019;45:669\u201376.","journal-title":"Russ J Bioorg Chem"},{"issue":"7","key":"1448_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.53","volume":"5","author":"MF Abushahba","year":"2016","unstructured":"Abushahba MF, Mohammad H, Seleem MN. Targeting Multidrug-resistant Staphylococci with an anti-rpoA peptide nucleic acid conjugated to the HIV-1 TAT cell penetrating peptide. Mol Ther Nucleic Acids. 2016;5(7):e339.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1448_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.112167","volume":"126","author":"MJ Beha","year":"2021","unstructured":"Beha MJ, Ryu JS, Kim YS, Chung HJ. Delivery of antisense oligonucleotides using multi-layer coated gold nanoparticles to methicillin-resistant S. aureus for combinatorial treatment. Mater Sci Eng C Mater Biol Appl. 2021;126:112167.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"7","key":"1448_CR44","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1128\/AAC.01542-08","volume":"53","author":"J Meng","year":"2009","unstructured":"Meng J, Wang H, Hou Z, Chen T, Fu J, Ma X, et al. Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA. Antimicrob Agents Chemother. 2009;53(7):2871\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1448_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-015-0599-x","volume":"15","author":"S Goh","year":"2015","unstructured":"Goh S, Loeffler A, Lloyd DH, Nair SP, Good L. Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro. BMC Microbiol. 2015;15:262.","journal-title":"BMC Microbiol"},{"key":"1448_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.70059","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Si J, Jing S, Wang B, Xu Y, Guan J, et al. Multifunctional framework nucleic acid vehicle for antibiotic sensitization and treatment of methicillin\u2010resistant Staphylococcus aureus. Aggregate (Hoboken). 2025. https:\/\/doi.org\/10.1002\/agt2.70059.","journal-title":"Aggregate (Hoboken)"},{"key":"1448_CR47","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2217\/fmb-2019-0103","volume":"14","author":"M Tavakoli","year":"2019","unstructured":"Tavakoli M, Hashemi A, Vaezjalali M, Mohammadzadeh M, Goudarzi H. Inhibition of growth and gene expression in Staphylococcus aureus by anti-gyrA peptide nucleic acid. Future Microbiol. 2019;14:1123\u201332.","journal-title":"Future Microbiol"},{"issue":"2","key":"1448_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ijpharm.2013.05.041","volume":"453","author":"AJ Sawyer","year":"2013","unstructured":"Sawyer AJ, Wesolowski D, Gandotra N, Stojadinovic A, Izadjoo M, Altman S, et al. A peptide-morpholino oligomer conjugate targeting Staphylococcus aureus gyrA mRNA improves healing in an infected mouse cutaneous wound model. Int J Pharm. 2013;453(2):651\u20135.","journal-title":"Int J Pharm"},{"issue":"1","key":"1448_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1021\/acsinfecdis.5c00600","volume":"12","author":"PJ Jire","year":"2026","unstructured":"Jire PJ, Sen V, Bharathwaj Y, Ramesh A. Antisense oligomer targeting the antibiotic resistance gene ermC augments erythromycin, azithromycin, and virginiamycin sensitivity in Staphylococcus aureus. ACS Infect Dis. 2026;12(1):139\u201351.","journal-title":"ACS Infect Dis"},{"issue":"1","key":"1448_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-023-01466-w","volume":"16","author":"Q Xiong","year":"2023","unstructured":"Xiong Q, Zhang Y. Small RNA modifications: regulatory molecules and potential applications. J Hematol Oncol. 2023;16(1):64.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1448_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3724\/abbs.2024196","volume":"57","author":"X Feng","year":"2024","unstructured":"Feng X, Guang S. Functions and applications of RNA interference and small regulatory RNAs: small RNAs and their functions. Acta Biochim Biophys Sin. 2024;57(1):119.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"7228","key":"1448_CR52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nature07758","volume":"457","author":"D Castanotto","year":"2009","unstructured":"Castanotto D, Rossi JJ. The promises and pitfalls of RNA-interference-based therapeutics. Nature. 2009;457(7228):426\u201333.","journal-title":"Nature"},{"issue":"3","key":"1448_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101997","volume":"6","author":"C Wang","year":"2025","unstructured":"Wang C, Sheng W, Zhou Y, Hang X, Zhao J, Gu Y, et al. siRNA-AGO2 complex inhibits bacterial gene translation: A promising therapeutic strategy for superbug infection. Cell Rep Med. 2025;6(3):101997.","journal-title":"Cell Rep Med"},{"issue":"10","key":"1448_CR54","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tree.2008.06.005","volume":"23","author":"SA Shabalina","year":"2008","unstructured":"Shabalina SA, Koonin EV. Origins and evolution of eukaryotic RNA interference. Trends Ecol Evol. 2008;23(10):578\u201387.","journal-title":"Trends Ecol Evol"},{"issue":"12","key":"1448_CR55","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3855\/jidc.13664","volume":"15","author":"TA Thompson","year":"2021","unstructured":"Thompson TA, Brown PD. Small interfering RNAs targeting agrA and sarA attenuate pathogenesis of Staphylococcus aureus in Caenorhabditis elegans. J Infect Dev Ctries. 2021;15(12):1868\u201375.","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"1448_CR56","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jac\/dki416","volume":"57","author":"K Yanagihara","year":"2006","unstructured":"Yanagihara K, Tashiro M, Fukuda Y, Ohno H, Higashiyama Y, Miyazaki Y, et al. Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo. J Antimicrob Chemother. 2006;57(1):122\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"1448_CR57","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.2147\/IDR.S494327","volume":"17","author":"MM Ahmed","year":"2024","unstructured":"Ahmed MM, Kayode HH, Okesanya OJ, Ukoaka BM, Eshun G, Mourid MR, et al. CRISPR-Cas systems in the fight against antimicrobial resistance: current status, potentials, and future directions. Infect Drug Resist. 2024;17:5229\u201345.","journal-title":"Infect Drug Resist"},{"key":"1448_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13010172","author":"J Ma","year":"2025","unstructured":"Ma J, Lu Z. Developing a versatile arsenal: novel antimicrobials as offensive tools against pathogenic bacteria. Microorganisms. 2025. https:\/\/doi.org\/10.3390\/microorganisms13010172.","journal-title":"Microorganisms"},{"issue":"7","key":"1448_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009672","volume":"17","author":"D Palacios Araya","year":"2021","unstructured":"Palacios Araya D, Palmer KL, Duerkop BA. CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria. PLoS Pathog. 2021;17(7):e1009672.","journal-title":"PLoS Pathog"},{"issue":"1","key":"1448_CR60","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41467-020-16731-6","volume":"11","author":"K Kiga","year":"2020","unstructured":"Kiga K, Tan XE, Ibarra-Ch\u00e1vez R, Watanabe S, Aiba Y, Sato\u2019o Y, et al. Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Nat Commun. 2020;11(1):2934.","journal-title":"Nat Commun"},{"issue":"12","key":"1448_CR61","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1002\/bit.27143","volume":"116","author":"X Wu","year":"2019","unstructured":"Wu X, Zha J, Koffas MAG, Dordick JS. Reducing Staphylococcus aureus resistance to lysostaphin using CRISPR-dCas9. Biotechnol Bioeng. 2019;116(12):3149\u201359.","journal-title":"Biotechnol Bioeng"},{"issue":"10","key":"1448_CR62","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt.4203","volume":"36","author":"G Ram","year":"2018","unstructured":"Ram G, Ross HF, Novick RP, Rodriguez-Pagan I, Jiang D. Conversion of staphylococcal pathogenicity islands to CRISPR-carrying antibacterial agents that cure infections in mice. Nat Biotechnol. 2018;36(10):971\u20136.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"1448_CR63","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1089\/crispr.2024.0001","volume":"7","author":"A Ates","year":"2024","unstructured":"Ates A, Tastan C, Ermertcan S. CRISPR-Cas9-mediated targeting of multidrug resistance genes in methicillin-resistant Staphylococcus aureus. Crispr j. 2024;7(6):374\u201384.","journal-title":"Crispr j"},{"issue":"4","key":"1448_CR64","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1021\/acs.bioconjchem.6b00676","volume":"28","author":"YK Kang","year":"2017","unstructured":"Kang YK, Kwon K, Ryu JS, Lee HN, Park C, Chung HJ. Nonviral genome editing based on a polymer-derivatized CRISPR nanocomplex for targeting bacterial pathogens and antibiotic resistance. Bioconjug Chem. 2017;28(4):957\u201367.","journal-title":"Bioconjug Chem"},{"issue":"1","key":"1448_CR65","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s42003-024-06754-w","volume":"7","author":"FY Li","year":"2024","unstructured":"Li FY, Tan XE, Shimamori Y, Kiga K, Veeranarayanan S, Watanabe S, et al. Phagemid-based capsid system for CRISPR-Cas13a antimicrobials targeting methicillin-resistant Staphylococcus aureus. Commun Biol. 2024;7(1):1129.","journal-title":"Commun Biol"},{"issue":"1","key":"1448_CR66","doi-asserted-by":"publisher","first-page":"16225","DOI":"10.1038\/s41598-024-67193-5","volume":"14","author":"Y Shimamori","year":"2024","unstructured":"Shimamori Y, Tan XE, Li FY, Nishikawa Y, Watanabe S, Sasahara T, et al. Efficient synthesis of CRISPR-Cas13a-antimicrobial capsids against MRSA facilitated by silent mutation incorporation. Sci Rep. 2024;14(1):16225.","journal-title":"Sci Rep"},{"issue":"11","key":"1448_CR67","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nbt.3043","volume":"32","author":"D Bikard","year":"2014","unstructured":"Bikard D, Euler C, Jiang W, Nussenzweig PM, Goldberg GW, Duportet X, et al. Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases. Nat Biotechnol. 2014;32(11):1146.","journal-title":"Nat Biotechnol"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01448-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01448-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01448-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:02:35Z","timestamp":1790272955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01448-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":67,"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01448-8","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"19 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Hamid Heidari and Reza Ghasemi declare that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}